This single case experiment compared the relative efficacy of imipramine hydrochloride and imipramine in conjunction with in vivo exposure and cognitive therapy, in the treatment of an agoraphobic. Results indicated that imipramine alone was ineffective in improving the client's phobic condition. However, the addition of the cognitive-behavioral intervention to imipramine proved extremely effective in altering phobic fear and avoidance behavior.
Get full access to this article
View all access options for this article.
References
1.
American Psychiatric Association.Diagnostic and statistical manual of mental disorders. (3rd ed.) Washington, DC: American Psychiatric Association, 1980.
2.
BarlowD. H.MavissakalianM.HayL. R.Couples trearment of agoraphobia: Changes in marital satisfaction. Behavior Research and Therapy, 1981, 19, 245–257.
3.
BarlowD. H.MavissakalianM. R.SchofieldL. D.Patterns of desynchrony in agoraphobia: A preliminary report. Behavior Research and Therapy, 1980, 18, 441–448.
4.
BarlowD. H.WolfeB. E.Behavioral approaches to anxiety disorders: A report on the NIMH-Suny Albany research conference. Journal of Clinical and Consulting Psychology, 1981, 49, 448–455.
5.
BeckA. T.Depression Inventory. Philadelphia: Center for Cognitive Therapy, 1978.
6.
ChamblessD. L.GoldsteinA. J.Clinical treatment of agoraphobia. In MavissakalianM.BarlowD. H. (Eds.), Phobia: Psychological and pharmacological treatment. New York: Guilford Press, 1981. Pp. 103–144.
7.
EmmelkampP. M. G.KuipersA. C. M.EggeraatJ. B.Cognitive modification versus prolonged exposure in vivo: A comparison with agoraphobics as subjects. Behaviour Research and Therapy, 1978, 16, 33–41.
8.
EmmelkampP. M. G.MerschP. P.Cognition and exposure in vivo in the treatment of agoraphobia: Short term and delayed effects. Cognitive Therapy and Research, in press.
9.
KleinD. F.Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia, 1964, 5, 397–408.
10.
KleinD. F.Importance of psychiatric diagnosis in prediction of clinical drug effects. Archives of General Psychiatry, 1967, 16, 118–126.
11.
KleinD. F.FinkM.Psychiatric reaction patterns to imipramine. American Journal of Psychiatry, 1962, 119, 432–438.
12.
KleinD. F.RabkinJ. G.Anxiety: New research and changing concepts. New York: Raven Press, 1981.
13.
MarksI. M.Exposure treatments: Clinical applications. In AgrasW. S. (Ed.), Behavior modification: Principles and clinical applications. (2nd ed.) Boston: Little Brown, 1978. Pp. 163–242.
14.
MathewsA.Fear reduction research and clinical phobias. Psychological Bulletin, 1978, 85, 390–404.
15.
MathewsA. M.GelderM. G.JohnstonD. W.Agoraphobia: Nature and treatment. New York: Guilford Press, 1981.
16.
MavissakalianM.BarlowD. H. (Eds.) Phobia: Psychological and pharmacological treatment. New York: Guilford Press, 1981.
17.
McNairD. M.KahnR. J.Imipramine compared with benzodiazepine for agoraphobia. In KleinD. F.RabkinJ. G. (Eds.), Anxiety: New research and changing concepts. New York: Raven Press, 1981. Pp. 69–80.
18.
MeichenbaumD.Cognitive behavior modification. New York: Plenum, 1977.
19.
RifkinA.KleinD. F.DillonD.LevittM.Blockade by imipramine or desipramine of panic induced by sodium lactate. American Journal of Psychiatry, 1981, 138, 676–677.
20.
SheehanD. V.BallengerJ.JacobsenG.Treatment of endogenous anxiety with phobic, hysterical, and hydrochondriacal symptoms. Archives of General Psychiatry, 1980, 37, 51–59.
21.
WatsonJ. P.MarksI. M.Relevant and irrelevant fear in flooding: A crossover study of phobic patients. Behavior Therapy, 1971, 2, 275–295.
22.
WilliamsS. L.RappoportA.Cognitive treatment in the natural environment for agoraphobics. Behavior Therapy, 1983, 14, 299–313.
23.
ZitrinC. M.KleinD. G.WoernerM. G.Behavior therapy, supportive psychotherapy, imipramine, and phobias. Archives of General Psychiatry, 1978, 35, 307–316.
24.
ZitrinC. M.KleinD. F.WoernerM. G.Treatment of agoraphobia with group exposure in vivo and imipramine. Archives of General Psychiatry, 1980, 37, 63–72.
